Search jobs 10-May-2021 Memory-Enhancing Drugs Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Alkem Laboratories Ltd., Paradigm Healthcare, Intas Pharmaceutical Ltd., Taurus Laboratories Pvt. Ltd., and Others
Memory-enhancing drugs are used for the treatment of diminished or decreased ability of person to memories due to traumatic injury to the central nervous system (CNS) or due to aging. The start of the memory loss or decreased cognition may result into the onset of the Alzheimer’s disease. Due to traumatic injury especially to the brain, brain cells tend to die and in case of aging person, although memory loss is common but it can be treated with memory-enhancing drugs.
Solara Active Pharma Sciences Ltd notched up volume of 14.26 lakh shares by 10:49 IST on BSE, a 119.32 fold spurt over two-week average daily volume of 11953 shares
Coforge Ltd, Phoenix Mills Ltd, GMM Pfaudler Ltd, Alkem Laboratories Ltd are among the other stocks to see a surge in volumes on BSE today, 10 May 2021.
Solara Active Pharma Sciences Ltd notched up volume of 14.26 lakh shares by 10:49 IST on BSE, a 119.32 fold spurt over two-week average daily volume of 11953 shares. The stock rose 2.13% to Rs.1,598.45. Volumes stood at 20107 shares in the last session.
Coforge Ltd notched up volume of 22.43 lakh shares by 10:49 IST on BSE, a 48.53 fold spurt over two-week average daily volume of 46207 shares. The stock slipped 5.15% to Rs.3,202.95. Volumes stood at 1.44 lakh shares in the last session.
Search jobs 07-May-2021 Memory-Enhancing Drugs Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Alkem Laboratories Ltd., Paradigm Healthcare, Intas Pharmaceutical Ltd., Taurus Laboratories Pvt. Ltd., and Others Memory-enhancing drugs are used for the treatment of diminished or decreased ability of person to memories due to traumatic injury to the central nervous system (CNS) or due to aging. The start of the memory loss or decreased cognition may result into the onset of the Alzheimer’s disease. Due to traumatic injury especially to the brain, brain cells tend to die and in case of aging person, although memory loss is common but it can be treated with memory-enhancing drugs.
Alkem Laboratories Ltd is quoting at Rs 2918.45, up 4.28% on the day as on 12:49 IST on the NSE. The stock is up 11.62% in last one year as compared to a 57.1% spurt in NIFTY and a 48.33% spurt in the Nifty Pharma index.
Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 2918.45, up 4.28% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.47% on the day, quoting at 14564.35. The Sensex is at 48614.59, up 0.75%. Alkem Laboratories Ltd has risen around 7.18% in last one month.
Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has risen around 9.07% in last one month and is currently quoting at 13234.75, up 3.41% on the day. The volume in the stock stood at 7.55 lakh shares today, compared to the daily average of 2.22 lakh shares in last one month.
ABCD Technologies onboards new partners to boost pharma supply chain
ABCD Technologies onboards new partners to boost pharma supply chain
03 May 2021 | News
Source credit: Shutterstock
ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) has announced that nine new partners have joined the initiative aimed at developing a world-class pharmaceutical supply chain & distribution IT ecosystem in India.
The new partners include Glenmark Pharmaceuticals Ltd, Emcure Pharmaceuticals Ltd, USV Private Ltd, Micro Labs Ltd, Alembic Pharmaceuticals Ltd, Cadila Pharmaceuticals Ltd, Ajanta Pharma Ltd, Ipca Laboratories Ltd and Intas Pharmaceuticals Ltd.
With the addition of new partners, ABCD Technologies LLP now has 17 partners. The companies who had joined earlier included Alkem Laboratories Ltd, Zydus HealthCare Ltd, Cipla Ltd, Dr Reddy’s Laboratories Ltd, Lupin Ltd, Mankind Pharma Ltd, Sun Pharma Distributors Ltd and Torrent Pharmaceuticals Ltd. The partnership is aimed at